NVR UL7 (Piqray 150 mg)
Generic Name: alpelisib
Pill with imprint NVR UL7 is Pink, Elliptical / Oval and has been identified as Piqray 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Piqray is used in the treatment of breast cancer; breast cancer, male and belongs to the drug class PI3K inhibitors. Piqray 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR UL7
Piqray
- Generic Name
- alpelisib
- Imprint
- NVR UL7
- Strength
- 150 mg
- Color
- Pink
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Pi3k inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0708
More about Piqray (alpelisib)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: PI3K inhibitors
- FDA Approval History
Consumer resources
- Patient Information
- Piqray 200MG Daily Dose (Advanced Reading)
- Piqray 250MG Daily Dose (Advanced Reading)
- Piqray 300MG Daily Dose (Advanced Reading)
- Piqray 200MG Daily Dose
- ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.